Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Halozyme Therapeutics, Inc. (HALO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Halozyme Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1159036.
Total stock buying since 2015: $921,080.
Total stock sales since 2015: $177,557,415.
Total stock option exercises since 2015: $23,264,372.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 52,000 | $3,988,880 | 57,611 | $603,500 |
| 2025 | 0 | $0 | 476,573 | $30,868,186 | 1,078,014 | $3,206,319 |
| 2024 | 0 | $0 | 334,881 | $17,629,478 | 424,975 | $4,439,299 |
| 2023 | 0 | $0 | 336,464 | $14,754,150 | 401,542 | $3,897,660 |
| 2022 | 0 | $0 | 105,000 | $5,871,515 | 197,474 | $879,600 |
| 2021 | 0 | $0 | 698,778 | $30,099,644 | 829,111 | $8,633,098 |
| 2020 | 52,629 | $748,700 | 331,134 | $11,719,121 | 344,979 | $1,018,599 |
| 2019 | 0 | $0 | 1,328 | $22,177 | 278,438 | $0 |
| 2018 | 0 | $0 | 3,509,484 | $61,570,864 | 233,201 | $0 |
| 2017 | 0 | $0 | 0 | $0 | 215,016 | $207,398 |
| 2016 | 0 | $0 | 0 | $0 | 122,450 | $153,100 |
| 2015 | 10,000 | $172,380 | 60,000 | $1,033,400 | 82,426 | $225,799 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-07 | Kelley Kenneth J | Sale | 35,086 | 41.00 | 1,438,526 |
| 2020-12-02 | Kelley Kenneth J | Sale | 31,792 | 41.00 | 1,303,472 |
| 2020-11-27 | Kelley Kenneth J | Sale | 10,000 | 41.25 | 412,500 |
| 2020-11-25 | Daly James M | Sale | 10,363 | 40.41 | 418,799 |
| 2020-11-25 | Torley Helen (President and CEO) | Sale | 50,000 | 40.68 | 2,033,850 |
| 2020-11-25 | Torley Helen (President and CEO) | Option Ex | 50,000 | 14.66 | 733,000 |
| 2020-11-25 | Henderson Jeffrey William | Sale | 24,498 | 40.08 | 981,757 |
| 2020-11-25 | Kelley Kenneth J | Sale | 9,671 | 41.50 | 401,346 |
| 2020-11-20 | Labarre Michael J. (SVP, Chief Technical Officer) | Sale | 12,000 | 38.64 | 463,680 |
| 2020-10-20 | Labarre Michael J. (SVP, Chief Technical Officer) | Sale | 12,000 | 30.43 | 365,148 |
| 2020-09-21 | Labarre Michael J. (SVP, Chief Technical Officer) | Sale | 12,000 | 26.91 | 322,884 |
| 2020-09-11 | Matsui Connie | Sale | 32,000 | 27.06 | 865,792 |
| 2020-09-04 | Matsuda Masaru (SVP, General Counsel) | Option Ex | 6,884 | .00 | 0 |
| 2020-08-20 | Labarre Michael J. (SVP, Chief Technical Officer) | Sale | 12,000 | 28.30 | 339,564 |
| 2020-08-13 | Daly James M | Sale | 34,337 | 29.12 | 999,893 |
| 2020-07-20 | Labarre Michael J. (SVP, Chief Technical Officer) | Sale | 12,000 | 29.01 | 348,072 |
| 2020-05-22 | Labarre Michael J. (SVP, Chief Technical Officer) | Option Ex | 18,613 | 7.14 | 132,896 |
| 2020-05-20 | Labarre Michael J. (SVP, Chief Technical Officer) | Sale | 21,387 | 23.80 | 509,074 |
| 2020-05-20 | Labarre Michael J. (SVP, Chief Technical Officer) | Option Ex | 21,387 | 7.14 | 152,703 |
| 2020-03-19 | Kelley Kenneth J | Buy | 52,629 | 14.23 | 748,700 |
| 2020-02-22 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 11,392 | .00 | 0 |
| 2020-02-22 | Torley Helen (President and CEO) | Option Ex | 39,354 | .00 | 0 |
| 2020-02-22 | Labarre Michael J. (SVP, Chief Technical Officer) | Option Ex | 8,803 | .00 | 0 |
| 2020-02-14 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 7,809 | .00 | 0 |
| 2020-02-14 | Torley Helen (President and CEO) | Option Ex | 28,730 | .00 | 0 |
| 2020-02-14 | Labarre Michael J. (SVP, Chief Technical Officer) | Option Ex | 5,772 | .00 | 0 |
| 2020-02-12 | Matsuda Masaru (SVP, General Counsel) | Option Ex | 4,130 | .00 | 0 |
| 2020-02-12 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 11,262 | .00 | 0 |
| 2020-02-12 | Torley Helen (President and CEO) | Option Ex | 32,795 | .00 | 0 |
| 2020-02-12 | Labarre Michael J. (SVP, Chief Technical Officer) | Option Ex | 7,883 | .00 | 0 |
| 2020-02-03 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 23,119 | .00 | 0 |
| 2020-02-03 | Torley Helen (President and CEO) | Option Ex | 55,487 | .00 | 0 |
| 2020-02-03 | Labarre Michael J. (SVP, Chief Technical Officer) | Option Ex | 11,559 | .00 | 0 |
| 2019-10-01 | Hickey Benjamin (SVP, Chief Commerical Officer) | Option Ex | 20,216 | .00 | 0 |
| 2019-08-03 | Chondros Dimitrios (SVP, Chief Medical Officer) | Sale | 1,328 | 16.70 | 22,177 |
| 2019-06-15 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 6,875 | .00 | 0 |
| 2019-06-01 | Chondros Dimitrios (SVP, Chief Medical Officer) | Option Ex | 2,043 | .00 | 0 |
| 2019-04-13 | Leonhardt Harry J (SVP, GC) | Option Ex | 6,875 | .00 | 0 |
| 2019-02-22 | Chondros Dimitrios (SVP, Chief Medical Officer) | Option Ex | 3,884 | .00 | 0 |
| 2019-02-22 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 11,392 | .00 | 0 |
| 2019-02-22 | Torley Helen (President and CEO) | Option Ex | 39,354 | .00 | 0 |
| 2019-02-22 | Leonhardt Harry J (SVP, GC) | Option Ex | 11,392 | .00 | 0 |
| 2019-02-14 | Chondros Dimitrios (SVP, Chief Medical Officer) | Option Ex | 6,790 | .00 | 0 |
| 2019-02-14 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 7,809 | .00 | 0 |
| 2019-02-14 | Torley Helen (President and CEO) | Option Ex | 28,730 | .00 | 0 |
| 2019-02-14 | Leonhardt Harry J (SVP, GC) | Option Ex | 7,809 | .00 | 0 |
| 2019-02-06 | Torley Helen (President and CEO) | Option Ex | 31,250 | .00 | 0 |
| 2019-02-03 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 23,119 | .00 | 0 |
| 2019-02-03 | Torley Helen (President and CEO) | Option Ex | 55,487 | .00 | 0 |
| 2019-02-03 | Leonhardt Harry J (SVP, GC) | Option Ex | 15,413 | .00 | 0 |
| 2018-08-28 | Kirk Randal J | Sale | 432,249 | 18.02 | 7,789,126 |
| 2018-08-27 | Kirk Randal J | Sale | 109,377 | 18.22 | 1,992,848 |
| 2018-08-24 | Kirk Randal J | Sale | 103,372 | 18.20 | 1,881,370 |
| 2018-08-23 | Kirk Randal J | Sale | 251,335 | 18.48 | 4,644,670 |
| 2018-08-22 | Kirk Randal J | Sale | 781,881 | 17.49 | 13,675,098 |
| 2018-08-21 | Kirk Randal J | Sale | 161,246 | 17.15 | 2,765,368 |
| 2018-08-16 | Kirk Randal J | Sale | 95,363 | 17.24 | 1,644,058 |
| 2018-08-15 | Kirk Randal J | Sale | 91,541 | 17.15 | 1,569,928 |
| 2018-08-14 | Kirk Randal J | Sale | 303,168 | 17.36 | 5,262,996 |
| 2018-08-10 | Kirk Randal J | Sale | 202,959 | 17.08 | 3,466,539 |
| 2018-08-09 | Kirk Randal J | Sale | 223,127 | 17.48 | 3,900,259 |
| 2018-08-08 | Kirk Randal J | Sale | 146,718 | 17.52 | 2,570,499 |
| 2018-07-27 | Kirk Randal J | Sale | 48,927 | 16.90 | 826,866 |
| 2018-07-26 | Kirk Randal J | Sale | 150,000 | 17.30 | 2,595,000 |
| 2018-07-25 | Kirk Randal J | Sale | 103,900 | 17.32 | 1,799,548 |
| 2018-06-29 | Kirk Randal J | Sale | 122,431 | 16.97 | 2,077,654 |
| 2018-06-28 | Kirk Randal J | Sale | 128,385 | 16.99 | 2,181,261 |
| 2018-06-27 | Kirk Randal J | Sale | 53,505 | 17.34 | 927,776 |
| 2018-06-15 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 6,875 | .00 | 0 |
| 2018-06-01 | Chondros Dimitrios (SVP, Chief Medical Officer) | Option Ex | 2,043 | .00 | 0 |
| 2018-04-13 | Leonhardt Harry J (SVP, GC and CCO) | Option Ex | 6,875 | .00 | 0 |
| 2018-02-22 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 11,392 | .00 | 0 |
| 2018-02-22 | Torley Helen (President and CEO) | Option Ex | 39,354 | .00 | 0 |
| 2018-02-22 | Leonhardt Harry J (SVP, GC and CCO) | Option Ex | 11,392 | .00 | 0 |
| 2018-02-06 | Torley Helen (President and CEO) | Option Ex | 31,250 | .00 | 0 |
| 2018-02-03 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 23,120 | .00 | 0 |
| 2018-02-03 | Torley Helen (President and CEO) | Option Ex | 55,487 | .00 | 0 |
| 2018-02-03 | Leonhardt Harry J (SVP, GC and CCO) | Option Ex | 15,413 | .00 | 0 |
| 2018-01-06 | Torley Helen (President and CEO) | Option Ex | 30,000 | .00 | 0 |
| 2017-06-15 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 6,875 | .00 | 0 |
| 2017-05-11 | Kirk Randal J | Option Ex | 10,000 | 10.37 | 103,699 |
| 2017-05-08 | Matsui Connie | Option Ex | 10,000 | 10.37 | 103,699 |
| 2017-04-13 | Leonhardt Harry J (SVP, GC and CCO) | Option Ex | 6,875 | .00 | 0 |
| 2017-02-06 | Torley Helen (President and CEO) | Option Ex | 31,250 | .00 | 0 |
| 2017-02-03 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 23,120 | .00 | 0 |
| 2017-02-03 | Countouriotis Athena (SVP and Chief Medical Officer) | Option Ex | 18,496 | .00 | 0 |
| 2017-02-03 | Torley Helen (President and CEO) | Option Ex | 55,487 | .00 | 0 |
| 2017-02-03 | Leonhardt Harry J (SVP, GC and CCO) | Option Ex | 15,413 | .00 | 0 |
| 2017-01-06 | Torley Helen (President and CEO) | Option Ex | 30,000 | .00 | 0 |
| 2017-01-05 | Countouriotis Athena (SVP and Chief Medical Officer) | Option Ex | 7,500 | .00 | 0 |
| 2016-06-30 | Countouriotis Athena (SVP and Chief Medical Officer) | Option Ex | 6,450 | .00 | 0 |
| 2016-06-30 | Torley Helen (President and CEO) | Option Ex | 13,500 | .00 | 0 |
| 2016-06-15 | Stelzer Laurie (SVP, Chief Financial Officer) | Option Ex | 6,875 | .00 | 0 |
| 2016-04-13 | Leonhardt Harry J (SVP, GC and CCO) | Option Ex | 6,875 | .00 | 0 |
| 2016-02-06 | Torley Helen (President and CEO) | Option Ex | 31,250 | .00 | 0 |
| 2016-01-13 | Falberg Kathryn E | Option Ex | 20,000 | 7.66 | 153,100 |
| 2016-01-06 | Torley Helen (President and CEO) | Option Ex | 30,000 | .00 | 0 |
| 2016-01-05 | Countouriotis Athena (SVP and Chief Medical Officer) | Option Ex | 7,500 | .00 | 0 |
| 2015-09-14 | Matsui Connie (Director) | Option Ex | 20,000 | 3.63 | 72,700 |
| 2015-08-28 | Kelley Kenneth J | Option Ex | 10,000 | 10.37 | 103,699 |
| 2015-08-20 | Stelzer Laurie (Chief Financial Officer) | Buy | 10,000 | 17.24 | 172,380 |
| 2015-06-18 | Kelley Kenneth J | Sale | 20,000 | 21.00 | 420,000 |
| 2015-06-05 | Kelley Kenneth J (Director) | Option Ex | 10,000 | 4.94 | 49,400 |
| 2015-03-05 | Kelley Kenneth J (Director) | Sale | 40,000 | 15.34 | 613,400 |
| 2015-02-06 | Ramsay David A (VP and Chief Financial Officer) | Option Ex | 7,088 | .00 | 0 |
| 2015-02-04 | Ramsay David A (VP and Chief Financial Officer) | Option Ex | 2,213 | .00 | 0 |
| 2015-02-02 | Ramsay David A (VP and Chief Financial Officer) | Option Ex | 3,125 | .00 | 0 |
| 2015-01-06 | Torley Helen (President and CEO) | Option Ex | 30,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of HALO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Halozyme Therapeutics, Inc. (symbol HALO, CIK number 1159036) see the Securities and Exchange Commission (SEC) website.